Vali kana kudineer for Vali kanam (Acute pharyngitis) in children

PHASE II NON RANDOMIZED CLINICAL STUDY ON VALI KANAM (ACUTR PHARYNGITIS) WITH THE EVALUATION OF SIDDHA TRIAL DRUG VALI KANA KUDINEER IN CHILDREN

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/07/034780

Enrollment

Registered

2021-07-12

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J029- Acute pharyngitis, unspecified

Interventions

Intervention1: Vali Kana Kudineer: 15-30 ml of decoction bd for 14 days Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: Fever Sore throat Hoarseness of Voice Cough Pharyngeal Tonsillar Erythema Cervical Adenopathy Rhinitis

Exclusion criteria

Exclusion criteria: Peritonsillar Abscess Rheumatic Fever Diptheria Infective Mononucleosis

Design outcomes

Primary

Measure	Time frame
Reduction in Centor Score Reduction in Clinical SymptomsTimepoint: 14 Days	—

Secondary

Measure	Time frame
Comparing The Safety Parameters Before and After TreatmentTimepoint: 14 Days	—

Countries

India

Contacts

Public ContactDr R Sivapriya

Governnment siddha medical college

drvranimd@yahoo.com6369113461

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026